全文获取类型
收费全文 | 37146篇 |
免费 | 2539篇 |
国内免费 | 227篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 2058篇 |
妇产科学 | 1576篇 |
基础医学 | 3181篇 |
口腔科学 | 310篇 |
临床医学 | 3804篇 |
内科学 | 11044篇 |
皮肤病学 | 612篇 |
神经病学 | 2703篇 |
特种医学 | 441篇 |
外科学 | 4093篇 |
综合类 | 1124篇 |
现状与发展 | 1篇 |
一般理论 | 10篇 |
预防医学 | 3249篇 |
眼科学 | 1108篇 |
药学 | 1558篇 |
1篇 | |
中国医学 | 204篇 |
肿瘤学 | 2682篇 |
出版年
2023年 | 319篇 |
2022年 | 167篇 |
2021年 | 483篇 |
2020年 | 435篇 |
2019年 | 232篇 |
2018年 | 694篇 |
2017年 | 665篇 |
2016年 | 834篇 |
2015年 | 783篇 |
2014年 | 741篇 |
2013年 | 1090篇 |
2012年 | 2767篇 |
2011年 | 3076篇 |
2010年 | 1162篇 |
2009年 | 1111篇 |
2008年 | 3065篇 |
2007年 | 2972篇 |
2006年 | 2631篇 |
2005年 | 2774篇 |
2004年 | 2924篇 |
2003年 | 2999篇 |
2002年 | 2332篇 |
2001年 | 1678篇 |
2000年 | 494篇 |
1999年 | 367篇 |
1998年 | 417篇 |
1997年 | 247篇 |
1996年 | 204篇 |
1995年 | 117篇 |
1994年 | 143篇 |
1993年 | 125篇 |
1992年 | 154篇 |
1991年 | 147篇 |
1990年 | 98篇 |
1989年 | 100篇 |
1988年 | 112篇 |
1987年 | 81篇 |
1986年 | 113篇 |
1985年 | 76篇 |
1984年 | 65篇 |
1983年 | 62篇 |
1982年 | 68篇 |
1981年 | 71篇 |
1980年 | 63篇 |
1979年 | 50篇 |
1978年 | 57篇 |
1977年 | 47篇 |
1975年 | 44篇 |
1974年 | 40篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Dignan FL Amrolia P Clark A Cornish J Jackson G Mahendra P Scarisbrick JJ Taylor PC Shaw BE Potter MN;Haemato-oncology Task Force of British Committee for Standards in Haematology;British Society for Blood Marrow Transplantation 《British journal of haematology》2012,158(1):46-61
A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD). This guideline includes recommendations for the diagnosis and staging of chronic GvHD as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be the effective control of GvHD while minimizing the risk of toxicity and relapse. 相似文献
992.
Diagnosis and management of acute graft-versus-host disease 总被引:1,自引:0,他引:1
Dignan FL Clark A Amrolia P Cornish J Jackson G Mahendra P Scarisbrick JJ Taylor PC Hadzic N Shaw BE Potter MN;Haemato-oncology Task Force of British Committee for Standards in Haematology;British Society for Blood Marrow Transplantation 《British journal of haematology》2012,158(1):30-45
A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of acute graft-versus-host disease. This guideline includes recommendations for the diagnosis and grading of acute graft-versus-host disease as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be effective control of graft-versus-host disease while minimizing risk of toxicity and relapse. 相似文献
993.
Czuczman MS Hess G Gadeberg OV Pedersen LM Goldstein N Gupta I Jewell RC Lin TS Lisby S Strange C Windfeld K Viardot A; Study Investigators 《British journal of haematology》2012,157(4):438-445
An international, Phase II trial was conducted to assess two doses of ofatumumab, a human CD20 monoclonal antibody, combined with cyclophosphamide (750 mg/m2), doxorubicin (50 mg/m2), prednisone (100 mg days 3–7) and vincristine (1·4 mg/m2) (O‐CHOP), as frontline treatment for follicular lymphoma (FL). 59 patients with previously untreated FL were randomized to ofatumumab 500 mg (n = 29) or 1000 mg (n = 30) day 1, with CHOP on day 3 every 3 weeks for six cycles. Median duration of FL was 0·1 years for both dose groups; 34% and 38% of patients had high‐risk Follicular Lymphoma International Prognostic Index (FLIPI) scores in the 500‐ and 1000‐mg dose groups, respectively. Overall response rate was 90% for the 500‐mg group and 100% for the 1000‐mg group. 62% of patients achieved complete response (CR)/unconfirmed CR (CRu). 76% of patients with FLIPI score 3–5 attained CR/CRu. Longer follow‐up time is needed for analysis of survival end points. The most common Common Terminology Criteria grade 3–4 investigator‐reported adverse events were leucopenia (29%) and neutropenia (22%). No deaths have been reported. O‐CHOP was safe and efficacious in patients with previously untreated FL, including high‐risk FLIPI groups. This trial was registered at www.clinicaltrials.gov (NCT00494780). 相似文献
994.
Taal HR Verwoert GC Demirkan A Janssens AC Rice K Ehret G Smith AV Verhaaren BF Witteman JC Hofman A Vernooij MW Uitterlinden AG Rivadeneira F Ikram MA Levy D van der Heijden AJ;Cohort for Heart Aging Research in Genome Epidemiology Early Genetics Lifecourse Epidemiology consortia Jaddoe VW van Duijn CM 《Hypertension》2012,59(2):241-247
Hypertension is an important determinant of cardiovascular morbidity and mortality and has a substantial heritability, which is likely of polygenic origin. The aim of this study was to assess to what extent multiple common genetic variants contribute to blood pressure regulation in both adults and children and to assess overlap in variants between different age groups, using genome-wide profiling. Single nucleotide polymorphism sets were defined based on a meta-analysis of genome-wide association studies on systolic blood pressure and diastolic blood pressure performed by the Cohort for Heart and Aging Research in Genome Epidemiology (n=29 136), using different P value thresholds for selecting single nucleotide polymorphisms. Subsequently, genetic risk scores for systolic blood pressure and diastolic blood pressure were calculated in an independent adult population (n=2072) and a child population (n=1034). The explained variance of the genetic risk scores was evaluated using linear regression models, including sex, age, and body mass index. Genetic risk scores, including also many nongenome-wide significant single nucleotide polymorphisms, explained more of the variance than scores based only on very significant single nucleotide polymorphisms in adults and children. Genetic risk scores significantly explained ≤1.2% (P=9.6*10(-8)) of the variance in adult systolic blood pressure and 0.8% (P=0.004) in children. For diastolic blood pressure, the variance explained was similar in adults and children (1.7% [P=8.9*10(-10)] and 1.4% [P=3.3*10(-5)], respectively). These findings suggest the presence of many genetic loci with small effects on blood pressure regulation both in adults and children, indicating also a (partly) common polygenic regulation of blood pressure throughout different periods of life. 相似文献
995.
J Ishikawa S Hoshide K Eguchi S Ishikawa K Shimada K Kario;for the Japan Morning Surge-Home Blood Pressure Study Investigators Group 《Hypertension》2012,60(4):921-928
In ambulatory blood pressure (BP) monitoring, nighttime BP has a superior ability to predict hypertensive target organ damage than awake BP. We evaluated whether nighttime BP, assessed by a home BP monitor, was associated with hypertensive target organ damage. We measured clinic BP, out-of-clinic BP including nighttime home BP, and the urinary albumin:creatinine ratio (UACR) in 854 patients who had cardiovascular risk factors. Nighttime home BP was measured at 2:00, 3:00, and 4:00 am, in addition to clinic, awake ambulatory, nighttime ambulatory, and awake home BP. Nighttime home systolic BP (SBP) was slightly higher than nighttime ambulatory SBP (difference, 2.6 mm Hg; P<0.001). Clinic (r=0.186), awake ambulatory (r=0.173), nighttime ambulatory (r=0.194), awake home (r=0.298), and nighttime home (r=0.311) SBPs were all associated with log-transformed UACR (all P<0.001). The correlation coefficient for the relationship between nighttime home SBP and log-transformed UACR was significantly greater than that for the relationship between nighttime ambulatory SBP and log-transformed UACR (P<0.001). The goodness of fit of the association between SBP and UACR was improved by adding nighttime home SBP to the other SBPs (P<0.001). Nighttime home diastolic BP also improved the goodness-of-fit of the association between diastolic BP and UACR (P=0.001). Similar findings were observed for the left ventricular mass index in the subgroup (N=594). In conclusion, nighttime home BP is slightly different from (but comparable to) nighttime ambulatory BP. The addition of nighttime home BP to other BP measures improves the association of BP with hypertensive target organ damage. 相似文献
996.
Thygesen K Mair J Giannitsis E Mueller C Lindahl B Blankenberg S Huber K Plebani M Biasucci LM Tubaro M Collinson P Venge P Hasin Y Galvani M Koenig W Hamm C Alpert JS Katus H Jaffe AS;the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care 《European heart journal》2012,33(18):2252-2257
997.
998.
Zarski JP Sturm N Guechot J Paris A Zafrani ES Asselah T Boisson RC Bosson JL Guyader D Renversez JC Bronowicki JP Gelineau MC Tran A Trocme C De Ledinghen V Lasnier E Poujol-Robert A Ziegler F Bourliere M Voitot H Larrey D Rosenthal-Allieri MA Fouchard Hubert I Bailly F Vaubourdolle M;ANRS HCEP Fibrostar Group 《Journal of hepatology》2012,56(1):55-62
999.
Turin TC Murakami Y Miura K Rumana N Kadota A Ohkubo T Okamura T Okayama A Ueshima H;NIPPON DATA Research Group 《Diabetes research and clinical practice》2012,96(2):e18-e22
Life expectancy (LE) among the Japanese population with or without diabetes mellitus was estimated. LE in 40-year old men and women was 41.1 and 47.5 years in those without diabetes and 32.3 and 40.9 years in those with diabetes. The LE of 40-year old men and women with diabetes was 8.8 and 6.6 years shorter than in those without diabetes. Diabetes mellitus leads to a decrease in LE. The presence of impaired glucose tolerance also affected LE inversely. 相似文献
1000.
Fukumoto S Ishimura E Motoyama K Morioka T Kimoto E Wakikawa K Shoji S Koyama H Shoji T Emoto M Nishizawa Y Inaba M;Cilnidipine vs L-type calcium channel blockers Evaluation of Antihypertensive Renoprotective Effects in Diabetic patients 《Diabetes research and clinical practice》2012,97(1):91-98
We evaluated the antialbuminuric advantage of cilnidipine, an N/L-type calcium channel blocker (CCB), compared with L-type CCBs in diabetic patients with normoalbuminuria and microalbuminuria. The study was a multicenter, non-randomized crossover trial. Participants were 90 type 2 diabetic patients exhibiting either normo- or microalbuminuria, and undergoing CCB treatment for ≥6 months prior to study entry. The CCB at the time of entry was continued for the first 6 months (Period 1). Treatment was subsequently switched from cilnidipine to an L-type CCB, or vice versa, for the second 6-month observation period (Period 2). During Period 1, the L-type CCB group showed a significant increase of urinary albumin excretion (UAE) over time, while the cilnidipine group showed no significant elevation. During Period 2, switching of the treatment from the L-type CCB to cilnidipine resulted in significant reduction of the UAE, whereas switching from cilnidipine to the L-type CCB resulted in no significant change in the UAE. This study demonstrated that the antialbuminuric effect of Cilnidipine, but not the L-type CCBs, was sustained even in patients treated for a long time. In addition, the antialbuminuric effect can be anticipated after switching from an L-type CCB to cilnidipine, but not vice versa. 相似文献